YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Teicoplanin Administration in a Case of Endocarditis With Vancomycin-Induced Neutropenia

dc.authorscopusid 55640373400
dc.authorscopusid 7005791514
dc.authorscopusid 7004442897
dc.authorscopusid 14526773500
dc.authorscopusid 6603814316
dc.contributor.author Bay, A.
dc.contributor.author Öner, A.F.
dc.contributor.author Üner, A.
dc.contributor.author Doĝan, M.
dc.contributor.author Cesur, Y.
dc.date.accessioned 2025-05-10T17:51:19Z
dc.date.available 2025-05-10T17:51:19Z
dc.date.issued 2006
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Bay A., Yüzüncü Yil Üniversitesi Tip Fakültesi, Turkey, Department of Pediatrics, Yüzüncü Yil University Faculty of Medicine, Van, Turkey; Öner A.F., Yüzüncü Yil Üniversitesi Tip Fakültesi, Turkey, Department of Pediatrics, Yüzüncü Yil University Faculty of Medicine, Van, Turkey; Üner A., Yüzüncü Yil Üniversitesi Tip Fakültesi, Turkey, Department of Pediatrics, Yüzüncü Yil University Faculty of Medicine, Van, Turkey; Doĝan M., Yüzüncü Yil Üniversitesi Tip Fakültesi, Turkey, Department of Pediatrics, Yüzüncü Yil University Faculty of Medicine, Van, Turkey; Cesur Y., Yüzüncü Yil Üniversitesi Tip Fakültesi, Turkey, Department of Pediatrics, Yüzüncü Yil University Faculty of Medicine, Van, Turkey en_US
dc.description.abstract Neutropenia is an uncommon adverse effect associated with prolonged vancomycin therapy. The vancomycin-induced neutropenia is believed to be immunologically based and independent of drug concentrations. Neutrophil counts normally recover after discontinuation of vancomycin in this situation, but treatment options are needed for those patients who require ongoing antibiotic therapy. We report an eight year-old boy with infective endocarditis and vancomycin-induced neutropenia in which the neutropenia resolved after vancomycin was replaced by the structurally related compound teicoplanin. Patients should have periodic assessment of white blood cell and neutrophil counts and discontinuation of vancomycin should be considered if neutropenia develops. en_US
dc.identifier.endpage 38 en_US
dc.identifier.issn 0010-0161
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-33645291524
dc.identifier.scopusquality Q4
dc.identifier.startpage 36 en_US
dc.identifier.uri https://hdl.handle.net/20.500.14720/18084
dc.identifier.volume 49 en_US
dc.identifier.wosquality N/A
dc.language.iso tr en_US
dc.relation.ispartof Cocuk Sagligi ve Hastaliklari Dergisi en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Neutropenia en_US
dc.subject Teicoplanin en_US
dc.subject Vancomycin en_US
dc.title Teicoplanin Administration in a Case of Endocarditis With Vancomycin-Induced Neutropenia en_US
dc.type Article en_US

Files